Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoradiotherapy in Gallbladder and Extrahepatic Cholangiocarcinoma
NCT02798510Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Apr 2016
- Primary completion
- Apr 2019
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, gemcitabine in gallbladder carcinoma, extrahepatic cholangiocarcinoma (eCCA), sponsored by Fudan University. Status: unknown.
02
Drugs
capecitabinegemcitabine
03
Conditions
gallbladder carcinomaextrahepatic cholangiocarcinoma (eCCA)
Beyond the preview
Go deeper on NCT02798510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798510.